News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
State-of-the-art biomimetic tissue engineered technologies for cancer research
Aug 21, 2024, 19:50

State-of-the-art biomimetic tissue engineered technologies for cancer research

NCI Physical Sciences shared a post on X:

“The Cancer Tissue Engineering Collaborative Program of National Cancer Institute supports the development and characterization of state-of-the-art biomimetic tissue engineered technologies for cancer research.”

State-of-the-art biomimetic tissue engineered technologies for cancer research

Source: NCI Physical Sciences/X

cancer National Cancer Institute NCI Physical Sciences OncoDaily Oncology
Special Coverage
Societies
Sep 4, 2025, 03:12
Join the UNGA80 Side Event on Childhood Cancer - SIOP
Societies
Sep 4, 2025, 03:01
Excited to Announce the ASCOQLTY25 Featured Voices – ASCO
Voices
Sep 4, 2025, 00:02
Chris Poulios: Live from the Vision Europe 2030 Meeting of EAPM
Societies
Sep 3, 2025, 23:42
The SIOG 2025 Annual Conference: A Milestone Congress Celebrating 25 years of SIOG
Voices
Sep 3, 2025, 23:15
Hesham ElGhazaly: Global Inclusion in Clinical Trials at Vision Europe 2025
Insight
Sep 3, 2025, 23:00
Eduardo Bruera: Addressing Psychosocial Needs in Young Adult Cancer Patients
Insight
Sep 3, 2025, 22:35
Raising Awareness for Head and Neck Cancer - European Cancer Organisation
Insight
Sep 3, 2025, 22:09
Felipe Couñago: A Timely and Inspiring Contribution to Neuro-Oncology
Voices
Sep 3, 2025, 21:42
Nagi El Saghir: Honored to Speak at Superb Festschrift Conference Honoring Fadlo Khuri
Voices
Sep 3, 2025, 21:16
Nelson Dusetti to Present on Pancreatic Cancer at Ramón Areces Foundation Symposium
Insight
Sep 3, 2025, 20:48
Advancing Patient-Centered Cancer Care Worldwide - UICC
Insight
Sep 3, 2025, 20:35
Nicola Fusco: Rare Tumors Deserve Our Best Research Efforts